Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹325.00
Market cap: ₹14,728 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 28.5×Sector 47.4×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

26 May 2026 13:30 IST BSE

Marksans Pharma Results Update

Marksans Pharma reported a record FY26 total income of ₹3,033.5 Crore, up 12.8% YoY. The company achieved historic highs in revenue, EBITDA, and PAT during the year.

Value: ₹3,034 Cr

Read the filing ↗